In Wake of Howard Schultz’s Starbucks Exit, Just How Impactful Can An Executive Departure Be to Retailers?

The departure of a Chief Executive Officer, whether it be abrupt or planned, can have major ripple effects on shareholders, employees, and customers alike. The recent departure of Starbucks Executive Chairman Howard Schultz has led many wondering the impact a change at the highest levels of management will have on the booming coffee enterprise.

Howard Schultz stepped down as CEO in 2017 to take on a role as Executive Chairman yet is often mistaken as the current Chief Executive. The impact Schultz has had on the company’s growth over the years has even superseded his departure from the position. Under Schultz’s helm, Starbucks stock has grown 21,000 percent since its initial public offering in 1992. Schultz has also been a champion while on the board for broadly expanding employee benefits, including providing healthcare to every barista working at least 20 hours, and global hiring initiatives—specifically for families of veterans and refugees.

The exit of a leader with such an important standing in a company cannot be understated.

“The problem with a large multinational company being tied too closely to a particular individual is that it makes a departure more monumental,” Dan Hill, CEO of Hill Impact, told CNBC.

Current CEO Kevin Johnson has already had to play damage control after a viral, racially charged incident occurred at one of its Philadelphia locations. Starbucks stock ($SBUX) has seen a mild loss over the last 30 days—perhaps due to recent events, but the company is continuing to innovate. The recent announcement of a Starbucks and JP Morgan Chase partnership has provided hope for shareholders that the company, in spite of executive departures, will continue to improve and expand on their successful business model.

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More